Trichohepatoenteric syndrome

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

9 events
Jan 2026Promoting Socioemotional Development in Early Childhood: Implementation and Evaluation of the VIPP-SD Parenting Intervention in Portugal

ISPA - Instituto Universitario de Ciencias Psicologicas, Sociais e da Vida — NA

TrialRECRUITING
Jan 2026Online Parenting Support With VIPP-SD in Chile

Universidad San Sebastián — NA

TrialNOT YET RECRUITING
Mar 2025Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens for the Treatment of Potentially Hazardous Colorectal Cancer SD Status

Sun Jing — PHASE2

TrialRECRUITING
Jan 2025This Project At LMU Looks At How Using AI 2nd Opinion Report to Analyze Retinal Eye Scans Impact Doctors' Decisions About Treatment for Patients with a Specific Eye Disease (nAMD)

Johannes Schiefelbein — NA

TrialNOT YET RECRUITING
Dec 2024Sd-RAB for the Diagnosis of PPLs

Shanghai Chest Hospital — NA

TrialNOT YET RECRUITING
Jan 2024The Sequencing for Detection in Congenital Heart Disease (SD-CHD) Study

Scripps Translational Science Institute — NA

TrialRECRUITING
Oct 2023Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan

Brigham and Women's Hospital — PHASE4

TrialENROLLING BY INVITATION
Oct 2013SD-OCT Measurement of the Human Retina in Pregnancy With Pre-existing or De Novo Hypertension and Without Hypertension

University of Calgary

TrialACTIVE NOT RECRUITING
Aug 2007

Somatuline Depot: FDA approved

Long-term treatment of acromegalic patients who have had an inadequate response to or cannot be treated with surgery and/or radiotherapy

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Trichohepatoenteric syndrome.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Somatuline Depot

(Lanreotide)Orphan drug

IPSEN, Inc.

12.1 Mechanism of Action Lanreotide, the active component of SOMATULINE DEPOT is an octapeptide analog of natural somatostatin. The mechanism of actio...

Approved Aug 2007FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Trichohepatoenteric syndrome.
Search all trials →
Search clinical trials for Trichohepatoenteric syndrome

Recent News & Research

No recent news articles indexed yet for Trichohepatoenteric syndrome.
Search PubMed for Trichohepatoenteric syndrome

Browse all Trichohepatoenteric syndrome news →

Specialist Network

No specialists currently listed for Trichohepatoenteric syndrome.

View all Trichohepatoenteric syndrome specialists →

Quick Actions